CELLINK
-
Swedish bioprinting firm CELLINK has announced it has formed an alliance with Swiss chemicals and biotech company Lonza. Through the agreement, the partners will combine CELLINK’s 3D bioprinting systems and bioinks with Lonza’s primary cells and culture media to offer a complete 3D bioprinting solution for 3D cell culture workflows.…
Read More -
Bioprinting company CELLINK has announced it has entered into an agreement with life science company cytena GmbH to acquire all of the company’s shares for €30.25 million (roughly $33.87 million). The acquisition is expected to bolster CELLINK’s commercial strategy and strengthen its product offering. cytena was founded in 2014 as…
Read More -
The very niche subsegment of 3D bioprinting in space has had a development that we’re excited to report: Swedish bioprinting company CELLINK recently announced that it sent 3D bioprinted stem cells into space. The initiative, brought to fruition through a partnership with scientists from Uppsala University, aims to accelerate the…
Read More -
Vladimir Mironov, Chief Scientific Officer at 3D Bioprinting Solutions (3D Bio) and Leading Scientist at Regenerative Medicine Institute of the Moscow Sechenov Medical University, Russia will be the main instructors for the course in bioprinting and regenerative medicine organized by the Universidad de Los Andes in Bogotà, Colombia. At 3D…
Read More -
Bioprinting company CELLINK is continually striving to advance the possibilities of additive manufacturing in the medical, and specifically bioprinting, field. To highlight its efforts, the company recently hosted a Collaborative Partnership Conference on May 10 in Milan, Italy. The event was the perfect opportunity to showcase the technological solutions offered by the…
Read More -
After INKing a number of high profile collaboration deals, CELLINK is now launching yet another a partnership with Volumetric, a Texas-based startup. The two companies will combine their expertise to develop and launch the new Lumen X bioprinter and more technologies to come in the future. The Lumen X leverages a…
Read More -
Swedish bioprinting company CELLINK has received SEK 10 million in funding (roughly €965,775) from the EU to pursue a bioink development project in collaboration with the Academisch Centrum Tandheelkunde Amsterdam (ACTA). The initiative is called the Functionalized Collagen-based Bioink for 3D Bioprinting project, or FUNC for short. The FUNC project…
Read More -
Swedish bioprinting company CELLINK has entered into a partnership with organ and tissue engineering company Prellis Biologics, Inc. with the goal of commercializing high-resolution holographic bioprinting technology for micro-scale printing. By combining their IP and respective expertise, the companies will introduce what they call the “first system enabling ultra-high resolution…
Read More -
Swedish 3D bioprinter manufacturer CELLINK is launching a brand new bioink containing BIOLAMININ, that will enable scientists to combine the unique properties of the laminin protein with culturing cells in a 3D-environment. This approach will advance the 3D bioprinting technology since the biological effect of the laminin protein will improve…
Read More -
CELLINK, the Swedish startup that created one of the first universal bioinks and manufacturers cost effective bioprinters, is working on a EU co-funded project called TumorPrint. The project aims to develop and commercialize a Specific Bioprinting platform, including bioinks, software and hardware, specialized for printing of human cancer tumors. The total…
Read More
